Eva Castellano

513 total citations
10 papers, 255 citations indexed

About

Eva Castellano is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Eva Castellano has authored 10 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Immunology and 3 papers in Surgery. Recurrent topics in Eva Castellano's work include CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). Eva Castellano is often cited by papers focused on CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). Eva Castellano collaborates with scholars based in Spain, United States and Italy. Eva Castellano's co-authors include Jessica Encinas, Almudena García-Ortiz, Joaquín Martínez‐López, Joaquı́n Teixidó, Paula Rı́o, Antonio Valeri, Alejandra Leivas, Laura Córdoba, Fernando Sánchez-Toril and Eva M. García‐Cuesta and has published in prestigious journals such as Blood, Frontiers in Immunology and Cancers.

In The Last Decade

Eva Castellano

9 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Castellano Spain	6	138	123	101	84	28	10	255
Magdalena Hinterbrandner Switzerland	6	145 1.1×	117 1.0×	101 1.0×	105 1.3×	15 0.5×	7	270
Ayano Yurino Japan	6	113 0.8×	190 1.5×	136 1.3×	124 1.5×	18 0.6×	8	328
Winnie L. Kan Australia	5	76 0.6×	129 1.0×	55 0.5×	64 0.8×	19 0.7×	10	252
Corina Schneidawind Germany	12	84 0.6×	101 0.8×	118 1.2×	138 1.6×	36 1.3×	25	302
Shihong Yang Australia	10	180 1.3×	254 2.1×	220 2.2×	105 1.3×	27 1.0×	21	403
Hongbo Wang United States	8	154 1.1×	258 2.1×	67 0.7×	46 0.5×	10 0.4×	11	311
Mizuha Kosugi‐Kanaya Japan	8	85 0.6×	203 1.7×	62 0.6×	75 0.9×	16 0.6×	14	324
Jung Hyun Her South Korea	7	231 1.7×	265 2.2×	52 0.5×	46 0.5×	16 0.6×	8	325
Anni Skovbo Denmark	9	172 1.2×	247 2.0×	119 1.2×	110 1.3×	25 0.9×	13	403
Mariana L. Oliveira Portugal	8	78 0.6×	71 0.6×	59 0.6×	131 1.6×	23 0.8×	10	292

Countries citing papers authored by Eva Castellano

Since Specialization

Citations

This map shows the geographic impact of Eva Castellano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Castellano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Castellano more than expected).

Fields of papers citing papers by Eva Castellano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Castellano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Castellano. The network helps show where Eva Castellano may publish in the future.

Co-authorship network of co-authors of Eva Castellano

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Castellano. A scholar is included among the top collaborators of Eva Castellano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Castellano. Eva Castellano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Coletta, Diego, Valeria Cherubini, Elia Giuseppe Lunghi, et al.. (2025). Acute abdomen during chemotherapy: is surgery worthwhile? Insights from a single-center experience. Updates in Surgery. 77(8). 2293–2299.

Castellano, Eva, Almudena García-Ortiz, Jessica Encinas, et al.. (2024). CRISPR/Cas9 Multi-Editing Enhances CAR NK Cells Therapeutic Potential Against Multiple Myeloma. Blood. 144(Supplement 1). 3442–3442. 3 indexed citations

Encinas, Jessica, Almudena García-Ortiz, Eva Castellano, et al.. (2023). S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY. HemaSphere. 7(S3). e16745e9–e16745e9. 2 indexed citations

Santamaría, Silvia Santamaría, Eva Castellano, Cecilia Muñoz‐Calleja, et al.. (2022). Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9+ tumors. Frontiers in Immunology. 13. 825635–825635. 8 indexed citations

Valeri, Antonio, Almudena García-Ortiz, Eva Castellano, et al.. (2022). Overcoming tumor resistance mechanisms in CAR-NK cell therapy. Frontiers in Immunology. 13. 953849–953849. 64 indexed citations

Castellano, Eva, Gloria Esteso, Laura J. Simpson, et al.. (2022). CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients. Frontiers in Immunology. 13. 970931–970931. 8 indexed citations

García-Ortiz, Almudena, et al.. (2021). The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression. Cancers. 13(2). 217–217. 136 indexed citations

Encinas, Jessica, Almudena García-Ortiz, Eva Castellano, et al.. (2021). P-007: Exploring a safety switch in NKG2D and BCMA CAR NK-92MI immunotherapy. Clinical Lymphoma Myeloma & Leukemia. 21. S42–S43. 3 indexed citations

Ashiru, Omodele, Gloria Esteso, Eva M. García‐Cuesta, et al.. (2019). BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine. Cancers. 11(7). 940–940. 13 indexed citations

10.

Castellano, Eva, et al.. (2010). Primary Pulmonary Hodgkin’s Lymphoma. Canadian Respiratory Journal. 17(6). e106–e108. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact